Amitiza
Brand for: Lubiprostone
My Prescription
Payment
Select pharmacy
$36.75
Print or send this coupon to your phone
CVSPowered byAbout Amitiza
Drug Details
Lubiprostone is a medication designed to treat specific types of constipation, including chronic idiopathic constipation, irritable bowel syndrome with constipation (IBS-C) in women aged 18 or older, and constipation caused by opioid medications in individuals with ongoing pain from conditions other than cancer. This drug belongs to a class known as chloride channel activators. It functions by increasing the level of fluid in the intestines, which helps make stool passage smoother and easier, thus alleviating symptoms like bloating, abdominal discomfort, and the need to strain during bowel movements.
Price history for Amitiza (brand) & Lubiprostone (generic)
60 Capsules, 24MCG
Average retail price for Amitiza
Average retail price for Lubiprostone
Average SaveHealth price for Lubiprostone
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
Over the last 12 months, the average discount price of Amitiza is $72.85 using the SaveHealth savings card. That's an average savings of 85.19% on Amitiza with our discount card.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Amitiza (Lubiprostone) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 8MCG | 1 Capsule | $15.26 | $15.26 |
| 8MCG | 20 Capsules | $27.48 | $1.37 |
| 8MCG | 30 Capsules | $29.58 | $0.99 |
| 8MCG | 40 Capsules | $31.67 | $0.79 |
| 8MCG | 60 Capsules | $35.85 | $0.60 |
| 8MCG | 90 Capsules | $42.13 | $0.47 |
| 8MCG | 100 Capsules | $44.22 | $0.44 |
Amitiza FAQs
Amitiza is neither a traditional laxative nor a stool softener. It is a chloride channel activator used to treat certain types of constipation by increasing fluid secretion in the intestines, which helps to ease the passage of stool.
Linzess (linaclotide) and Amitiza (lubiprostone) are both medications used to treat certain types of constipation, but they work in different ways. Linzess is a guanylate cyclase-C agonist that increases the secretion of chloride and bicarbonate into the intestinal lumen, which helps to accelerate intestinal transit. Amitiza, on the other hand, is a chloride channel activator that increases fluid secretion in the intestines, also promoting bowel movements. Additionally, they may be prescribed for different specific conditions, such as irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). The choice between them depends on the specific condition being treated and the patient's response to the medication.
Amitiza (lubiprostone) is not typically associated with significant weight loss or gain. However, individual responses to medication can vary, and some people may experience changes in weight. It is important for individuals to monitor their weight and discuss any concerns with their healthcare provider.
Lubiprostone may have several disadvantages or side effects. Common side effects include nausea, diarrhea, headache, abdominal pain, and flatulence. Some individuals may experience more severe reactions such as difficulty breathing or chest tightness. It is also important to note that lubiprostone is not recommended for individuals with a history of bowel obstruction. As with any medication, it is essential to discuss potential risks and benefits with a healthcare provider.
Hair loss is not a commonly reported side effect of Amitiza (lubiprostone). If a patient experiences hair loss while taking this medication, it is advisable to consult with a healthcare provider to determine the cause and discuss any concerns.